Search results for: 'd2cb intelligent pharma'

The 2020s will see last-mile electricity infrastructure undergo some much-needed advancement,which will enhance the overall electricity system. It will become a smarter and a more responsive system, one in which a car could power a home or batteries could power an entire football stadium on match day. The possibilities will increase based on how co...

10 Sep 2024  |  Global  |  Technology Research

Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing

Infographics

×

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized...

22 Aug 2022  |  North America  |  Market Research

Artificial Intelligence Powers Highly Competitive Mobile Sales Force Automation (SFA) Market in North America

Predictive Analytics, Mobile Access, Strategic Partnering Drive Growth

Infographics

×

Key Issues Addressed

The job of a sales representative continues to become more challenging and complex, with the rep under pressure to work faster, harder, and smarter. Mobile Sales Force Automation (SFA) solutions are designed to provide sales personnel with the real-time information and guidance they need to sell successfully, including managing leads, forecasting a...

Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. In an era of personalized medicine, the current trajectory of growth witn...

In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...

This research service focuses on existing therapeutics and product pipeline for the treatment of Parkinsons Disease using Dopamine Replacement Therapies, Dopamine Agonists, MAO-inhibitors, COMT-inhibitors and other pharamcolgical approaches for current global interest. This research service does not cover vaccines. A product and pipeline assessmen...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

In this report, Frost & Sullivan examines the role of artificial intelligence (AI) in the healthcare sector. Stakeholders across the healthcare continuum increasingly use AI to cater to the descriptive, diagnostic, predictive, and prescriptive aspects of care provision. These aspects help improve healthcare delivery efficiency, provide personalized...

The demand for intelligent transportation system (ITS) has also evolved with the progress transportation systems have made over the years. However, effective utilization of transportation systems depends on proper management of input data sources which describe the performance of the system and the state of system controls. The nature and quality...